Document is current
Any future updates will be listed below
-
Authors
Ax, Elisabeth http://orcid.org/0000-0001-7553-5059
Jevnikar, Zala
Cvjetkovic, Aleksander http://orcid.org/0000-0002-9131-9791
Malmhäll, Carina http://orcid.org/0000-0001-6696-7570
Olsson, Henric
Rådinger, Madeleine http://orcid.org/0000-0002-0652-7378
Lässer, Cecilia http://orcid.org/0000-0003-1279-1746
-
Funding
Funding for this research was provided by:
Hjärt-Lungfonden (20170392)
Stiftelsen Lars Hiertas Minne (-)
Stiftelsen för Strategisk Forskning (ID16-0083)
Sahlgrenska Universitetssjukhuset (-)
VBG group Herman Krefting Foundation Asthma and Allergy (-)
- License Information
-
More Information
Article History
Received: 2 January 2020
Accepted: 19 May 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: Blood samples used in this study were from healthy volunteers and approved by the ethics committee at Gothenburg University (DNR 593–08) and all subjects provided written informed consent.
: Not applicable.
: E.A., Z.J. and H.O. are employees of, and hold stock/stock options, in AstraZeneca, which supported the study. C.L. and A.C. are inventors of patents using EVs as either therapeutic or diagnostics tools. C.M. and M.R. declare that they have no relevant conflicts of interest.
